Both in Pharmaceuticals
Coya Therapeutics vs MAIA Biotechnology
Over the past year COYA returned −46.2% and MAIA returned −5.2%; their daily moves had a correlation of 0.32.
COYA −46.2% MAIA −5.2%Growth of $1, one year, split-adjusted
| Metric | COYA | MAIA |
|---|---|---|
| Price | $3.23 | $1.10 |
| Market cap | $75.8M | $67.9M |
| Today | −10.53% | 0.00% |
| 1 month | −32.8% | −7.6% |
| 6 months | −24.2% | −20.9% |
| Year to date | −44.3% | −28.1% |
| 1 year | −47.2% | −16.0% |
| Revenue growth (YoY) | +49.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −2723.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.4× | — |
| Net cash | $43.2M | $27.6M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 47.2% |
| Short % of float | 7.2% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).